Mandelbaum Barrett PC’s newly launched Antitrust Practice is generating significant media attention, with both Law360 Pulse and the New Jersey Law Journal highlighting the firm’s strategic expansion and the growing demand for antitrust counsel amid increased enforcement and litigation activity. Together, the coverage reinforces the timely launch of the practice, led by co-chairs Harrison McAvoy and Grant Petrosyan, as businesses across industries face heightened scrutiny related to competition law, transactions, and government oversight.
In its feature, Law360 Pulse highlights the Firm’s ability to meet this demand through a multidisciplinary approach spanning litigation, investigations, merger review, and compliance. Harrison emphasized the Firm’s positioning and depth of experience noting, “We feel that Mandelbaum is perfectly positioned to respond to this moment, given its client base, and the depth of experience we have among the lawyers at the firm… together we have covered an entire toolbox that our clients need for competition-related issues.”
The article also highlights the strong alignment between the practice’s leadership. Harrison brings experience in high-stakes antitrust litigation, while Grant advises clients on complex disputes and regulatory matters. Drawing on increased client demand, Grant told Law360, “Even here at this firm, especially more recently, our clients have been facing various competition antitrust-related issues… in response to the marketplace and the issues that our clients are facing, we thought it was just an opportune and pivotal time to launch a practice.”
The New Jersey Law Journal similarly highlights the rise in antitrust litigation and enforcement activity, as well as the Firm’s focus on building a leading practice in the region. Harrison pointed to the Firm’s growth strategy, telling the Law Journal, “It’s our hope that we can build on the foundation we already have and grow to be the go-to firm for antitrust issues in the state of New Jersey.”
Both publications also point to the Firm’s focus on key industries such as healthcare, pharmaceuticals, and medical devices, where antitrust considerations continue to play a central role.
This dual recognition from leading national and regional legal publications reflects Mandelbaum Barrett’s commitment to addressing evolving client needs and building a premier antitrust practice in a rapidly shifting regulatory landscape.